Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease
NCT ID: NCT06027333
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2023-11-08
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim is to assess changes in self-efficacy and quality of life over time and to establish a control cohort for a later feasibility study on a educational and self-management intervention (currently in planning).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation Counselling for Patients with Interstitial Lung Disease
NCT06815185
Home-based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease
NCT05130034
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
NCT00692796
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
NCT01055730
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD
NCT04257630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inpatient rehabilitation
This is an uncontrolled observational study on patients undergoing usual care in pulmonary rehabilitation and care
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For Inselspital only: Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose
* Age ≥ 18 years
* Written informed consent
Exclusion Criteria
* Sarcoidosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Zurich University of Applied Sciences
OTHER
University of Zurich
OTHER
Berner Reha Zentrum AG
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Berner Reha Zentrum, Rehabilitation & Sports Medicine, Insel Group, University Hospital Berne
Bern, Heiligenschwendi, Switzerland
Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Thimo Marcin, PhD
Role: primary
Sabina Guler, PD MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BernerRehaZentrum
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.